𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Localized prostate cancer: Prostatectomy versus interstitial implantation

✍ Scribed by Joseph D. Schmidt


Publisher
John Wiley and Sons
Year
1992
Tongue
English
Weight
170 KB
Volume
49
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Interstitial implantation techniques in
✍ Sylvester, John; Blasko, John C.; Grimm, Peter; Ragde, Haakon πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 332 KB πŸ‘ 1 views

Brachytherapy is a radiotherapeutic technique that allows the physician to implant radioactive isotopes into a body cavity or directly into tissue. Different radioisotopes have unique characteristics that the brachytherapist may utilize for a particular situation. The use of brachytherapy is part of

Neoadjuvant therapy followed by prostate
✍ Guru Sonpavde; Kim N. Chi; Thomas Powles; Christopher J. Sweeney; Noah Hahn; Tho πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 134 KB

## Abstract The results of this assessment of the literature indicated that neoadjuvant therapy followed by prostatectomy may improve long‐term outcomes for patients with high‐risk localized disease. In addition, this approach provides a paradigm for evaluating the activity and mechanism of action

Neoadjuvant therapy followed by prostate
✍ Bridget F. Koontz; Judd Moul πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 41 KB

W e commend Sonpavde et al 1 on their review of neoadjuvant therapy prior to prostatectomy, which focused on neoadjuvant drug trials. The bulk of preoperative intervention trials for prostate cancer utilize neoadjuvant chemotherapy, but we would like to comment on the use of preoperative radiotherap

Reply to neoadjuvant therapy followed by
✍ Guru Sonpavde; Mark Garzotto; Kim N. Chi πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 41 KB

W e commend Sonpavde et al 1 on their review of neoadjuvant therapy prior to prostatectomy, which focused on neoadjuvant drug trials. The bulk of preoperative intervention trials for prostate cancer utilize neoadjuvant chemotherapy, but we would like to comment on the use of preoperative radiotherap